Zhiwei He

Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center

H指数:25

被引数:2,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting PSMD14 increases chemotherapeutic sensitivity to gemcitabine by inhibiting the WNT/β-catenin pathway and glycolysis in pancreatic cancer

靶向PSMD14通过抑制WNT/β-连环蛋白通路和糖酵解来增加胰腺癌对吉西他滨的化疗敏感性

Cell Death & Disease

IF9.6

2026-08-030

INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism

INHBA通过增强CTPS1稳定性并介导嘧啶代谢，促进胰腺癌的化疗耐药性。

Cancer Cell International

IF6

2025-11-170

OAAI

Screening drugs of Anemoside B4 for MFAP4 expression in osteosarcoma in PDTX to increase personalized medicine

在异种移植瘤模型中筛选安莫苷B4药物以增加MFAP4在骨肉瘤中的表达，从而提高个性化医疗水平

Discover Oncology

IF2.9

2025-08-110

OAAI

Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis

外泌体衍生的lnc-FAM72D-3通过MBNL1/FAK轴重塑肝细胞癌细胞骨架促进仑伐替尼耐药性

Drug Resistance Updates

IF21.7

2025-06-070

PRE

CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis

环状RNA-mTOR通过PSIP1/c-Myc轴促进肝细胞癌进展和仑伐替尼耐药性

ADVANCED SCIENCE

IF14.1

2025-04-150

OAAI

CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/ SOX15 axis

GENOMICS

IF3

2025-03-010

OAAI

Hyperoside ameliorates neuropathic pain by modulating the astroglial reactivity in the vlPAG

Hyperoside通过调节vlPAG中的星形胶质细胞反应性来改善神经病理性疼痛。

NEUROPHARMACOLOGY

IF4.6

2025-03-010

PRE

Biomimetic Fabrication and Osteogenic Effects of E7BMP-2 Peptide Coassembly Microspheres Based α-Tricalcium Phosphate with Silk Fibroin

仿生制备及基于α-磷酸三钙与丝素蛋白的E7BMP-2肽共组装微球的成骨效应

ACS APPLIED BIO MATERIALS

IF4.7

2025-02-130

PRE

CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance

CELL DEATH & DISEASE

IF9.6

2025-02-040

OAAI

A human GSDMD protein-derived cell-penetrating peptide enhances the antitumor effects of the proapoptotic peptide KLA

人源GSDMD蛋白衍生的穿膜肽增强了促凋亡肽KLA的抗肿瘤效果

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

IF4.9

2025-02-010

PRE

CANCER CELL INTERNATIONAL

IF6

2025-01-170

OAAI

TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4

TMOD3通过促进自噬依赖的ASCL4降解加速KRAS突变胰腺癌的免疫治疗抵抗

DRUG RESISTANCE UPDATES

IF21.7

2025-01-010

PRE

TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signaling pathway

CELL DEATH & DISEASE

IF9.6

2024-12-260

OAAI

Injectable osteogenic hydrogel based on antibiotic recognition for infected radial bone defect regeneration

MATERIALS & DESIGN

IF7.9

2024-05-013

OAAI

Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response

METABOLITES

IF3.7

2024-01-131

OAAI

Global research trends of diabetes remission: a bibliometric study

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-11-283

OAAI

FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis

FOXQ1通过调控LDHA介导的有氧糖酵解促进胰腺癌细胞增殖、肿瘤干性和侵袭转移

CELL DEATH & DISEASE

IF9.6

2023-10-2416

OAAI

Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-08-0916

OAAI

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-304

OAAI

Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-318

OAAI

Zhiwei He

个人简介

教育背景

工作经历

荣誉奖项

研究方向